G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

about

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

Item

http://www.wikidata.org/entity/Q37396062

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

@en

type

Item

label

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

@en

prefLabel

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

@en

P1476

G protein pathway suppressor 2 (GPS2) acts as a tumor suppressor in liposarcoma.

@en

P2093

Can-Rong Lu

http://www.w3.org/2001/XMLSchema#string

Feng-Jun Xiao

http://www.w3.org/2001/XMLSchema#string

Li-Sheng Wang

http://www.w3.org/2001/XMLSchema#string

Na Liu

http://www.w3.org/2001/XMLSchema#string

Pei-Yu Li

http://www.w3.org/2001/XMLSchema#string

Qing-Fang Li

http://www.w3.org/2001/XMLSchema#string

Shao-Xia Wang

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Huang

http://www.w3.org/2001/XMLSchema#string

Ying Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Two human cDNAs, including a homolog of Arabidopsis FUS6 (COP11), suppress G-protein- and mitogen-activated protein kinase-mediated signal transduction in yeast and mammalian cells

AMF1 (GPS2) modulates p53 transactivation

The basics of epithelial-mesenchymal transition

Formation of hMSH4-hMSH5 heterocomplex is a prerequisite for subsequent GPS2 recruitment

JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas

Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.

GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response.

Liposarcoma: new entities and evolving concepts.

Small RNA sequencing and functional characterization reveals MicroRNA-143 tumor suppressor activity in liposarcoma.

Diagnosis and management of lipomatous tumors.

P2888

s13277-016-5220-x

P304

13333-13343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-5220-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rong-Hua Yin

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27460081

http://www.w3.org/2001/XMLSchema#string

P932

5097092

http://www.w3.org/2001/XMLSchema#string